Alto Neuroscience Inc. Share Price
ANROAlto Neuroscience Inc. Stock Performance
Open $27.04 | Prev. Close $27.33 | Circuit Range N/A |
Day Range $26.72 - $28.63 | Year Range $2.71 - $28.63 | Volume 54,445 |
Average Traded $28.10 |
Alto Neuroscience Inc. Share Price Chart
About Alto Neuroscience Inc.
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Alto Neuroscience Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $27.04 | $27.55 | +0.79% |
16-Jul-26 | $27.57 | $27.33 | -1.88% |
15-Jul-26 | $27.89 | $27.86 | -0.30% |
14-Jul-26 | $28.56 | $27.94 | -0.43% |
13-Jul-26 | $25.96 | $28.06 | +5.91% |
10-Jul-26 | $27.34 | $26.50 | -4.69% |
09-Jul-26 | $26.95 | $27.80 | +6.03% |
FAQs on Alto Neuroscience Inc. Share Price
Can I buy Alto Neuroscience Inc. shares in India?
What is the share price of Alto Neuroscience Inc.?
What is the 5 year returns of Alto Neuroscience Inc.?
What are the high & low stock price of Alto Neuroscience Inc. today?
What is the 52-week high and low of Alto Neuroscience Inc. stock?